1-15 of 15
Wei He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis

Lisa Baumann Kreuziger, Megan Keenan, Hayley Dykhoff, Marie Hall, Kyle Campbell, Emily Cahill, Ryan Hanson, Dustin McEvoy, Wei He, Sayon Dutta, Rachel P. Rosovsky, Damon E. Houghton
Journal: Blood
Blood (2023) 142 (Supplement 1): 3687.
https://doi.org/10.1182/blood-2023-180864
Published: 2023
Journal Articles

Results from Multisite Implementation of Electronic Health Record Tools for Clinical Pre-Test Probability of Pulmonary Embolism in the Emergency Department

Damon E. Houghton, Lisa Baumann Kreuziger, Megan Keenan, Hayley Dykhoff, Kyle Campbell, Marie Hall, Heather Heaton, Kristine Thompson, Jaime Aranda, Sarah Balgord, Jonathan Rubin, Ali Raja, Sayon Dutta, Ryan Hanson, Dustin McEvoy, Wei He, Emily Cahill, Rachel P. Rosovsky
Journal: Blood
Blood (2023) 142 (Supplement 1): 5067.
https://doi.org/10.1182/blood-2023-180177
Published: 2023
Journal Articles

Exploring Alternative Dosing Regimens of Single-Agent Belantamab Mafodotin on Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: DREAMM-14

Malin Hultcrantz, David Kleinman, Pavandeep Ghataorhe, Astrid McKeown, Wei He, Thomas Ling, Roxanne C Jewell, Joseph Brunner, Julie Byrne, Laurie Eliason, Emma Scott, Joanna Opalinska
Journal: Blood
Blood (2021) 138 (Supplement 1): 1645.
https://doi.org/10.1182/blood-2021-152224
Published: 2021
Journal Articles

A Once Daily, Oral, Triple Combination of BTK Inhibitor, mTOR Inhibitor and IMiD for Treatment of Relapsed/Refractory Richter's Transformation and De Novo Diffuse Large B-Cell Lymphoma

Anthony R. Mato, MD, Stephen J. Schuster, MD, Francine M. Foss, MD, Iris Isufi, MD, Shalin K. Kothari, MD, Wei Ding, MD PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Allison C. Rosenthal, D.O., Jose F. Leis, MD PhD, Han W. Tun, MD, Kaitlin Kennard, RN, BSN, Allison R. Nelson, RN, Victoria Falco, BSN, Celina J. Komari, BS, Amber B. Koehler, PA-C, MS, Rachel Stowe, RN, Wei He, PhD, Albert Kearney, PhD, Min Gui, PhD, Tim McKinlay, Lindsey E Roeker, MD, Meghan C. Thompson, MD, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-138896
Published: 2020
Journal Articles

A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalidomide in Patients with Relapsed/Refractory CLL, DLBCL or Other B-Cell Lymphomas

Anthony R. Mato, MDMSCE, Stephen J Schuster, MD, Francine M. Foss, MD, Iris Isufi, MD, Wei Ding, MD PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Han W. Tun, MD, Muhamad Alhaj Moustafa, MD, Kaitlin Kennard, RN, BSN, Cara M King, MPH, Amber Koehler, PA-C, MS, Casey Aitken, Wei He, PhD, Albert Kearney, PhD, Min Gui, PhD, Barry Douglas Anderson, MD PhD, Allison C. Rosenthal, DO, Lindsey E. Roeker, MD, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 810.
https://doi.org/10.1182/blood-2019-126192
Published: 2019
Journal Articles

Phase I Study of First-in-Class Oral Triplet Therapy DTRM-555 in Relapsed/Refractory Lymphoma Patients through Fixed-Dose Combination and Synthetic Lethality

Scott F Huntington, MD MPH, Stephen J. Schuster, MD, Wei He, PhD, Tong Shen, PhD, Heather Walker, MPH, CCRP, Laura Leary, Kylie Boyhen, Jennifer Gill, CRNP, Elizabeth T Chatburn, BS, Kaitlin Kennard, RN, BSN, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, David L. Porter, MD, Ellen Napier, NP, Mitchell E. Hughes, PharmD, Tanya Latorre, RN, Kristy Walsh, BS, Colleen Dorsey, BSN, RN, Jakub Svoboda, MD, Victoria Addis, MD, Barry Douglas Anderson, MD PhD, Emily Leblond, Yuqin Song, MD PhD, Jun Zhu, MD PhD, Lijuan Deng, MD PhD, Danielle M. Brander, MD, Wei Ding, MD PhD, Allison C. Rosenthal, DO, Han Tun, MD, Anthony R. Mato, MD MSCE
Journal: Blood
Blood (2018) 132 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2018-99-112944
Published: 2018
Journal Articles

Simultaneous Global Phase I Studies of a Differentiated BTK Inhibitor, Dtrmwxhs-12, in Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia and B-Cell Lymphomas

Yuqin Song, MD, Stephen J. Schuster, MD, Wei He, PhD, Jun Zhu, BS, Lijuan Deng, MD, Yingli Sun, MD, Ning Ding, MD, Xiaogan Wang, MD, Jennifer Gill, NP, MSN, Elizabeth T Chatburn, BS, Kaitlin Kennard, RN, BSN, Barry Douglas Anderson, MD PhD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, David L Porter, MD, Ellen Napier, NP, Mitchell E. Hughes, PharmD, BCPS, BCOP, Tanya Latorre, BSN, RN, Kristy Walsh, BS, Colleen Dorsey, BSN, Jakub Svoboda, MD, Victoria Addis, MD, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4056.
https://doi.org/10.1182/blood.V130.Suppl_1.4056.4056
Published: 2017
Journal Articles

MNK1 Inhibitor CGP57380 Overcomes the Activation of eIF4E Induced By mTORC1 Inhibitor: The Mechanism of Synergic Killing on T-ALL Cells

XianBo Huang, PhD, Wei He, MS, Jie Jin, MD, Wenbin Qian, MD
Journal: Blood
Blood (2014) 124 (21): 5215.
https://doi.org/10.1182/blood.V124.21.5215.5215
Published: 2014
Journal Articles

TIF1γ Knockdown Enhances Hematopoietic Stem Cell Self Renewal with Preferential Myeloid Differentiation and Delayed Erythropoiesis

David C Dorn, MD, Wei He, Joan Massague, Malcolm A.S. Moore, D.Phil
Journal: Blood
Blood (2011) 118 (21): 4829.
https://doi.org/10.1182/blood.V118.21.4829.4829
Published: 2011
Journal Articles

Pretreatment with Anti-CD3 Monoclonal Antibody Depletes Recipient CCR7 + Dendritic Cells and Prevents Graft-Versus-Host Disease While Preserving GVL Effects,

Can Liu, MD, Wei He, MD, Xiaofan Li, MD, Heather F Johnston, Miao Wang, MD, Jeremy Racine, Paul J Martin, MD, Stephen Forman, MD, Defu Zeng, MD
Journal: Blood
Blood (2011) 118 (21): 4024.
https://doi.org/10.1182/blood.V118.21.4024.4024
Published: 2011
Journal Articles

Tissue Parenchymal Cell Expression of B7-H1 Inhibits Infiltrating T Cell Expansion and Prevents Persistence of Graft-Versus-Host Disease

Xiaofan Li, MD, Wei He, MD, Ruishu Deng, MD, Can Liu, MD, Miao Wang, MD, James Young, Lieping Chen, MD, PhD, Yuan-Zhong Chen, MD, Paul J Martin, MD, Stephen Forman, MD, Defu Zeng, MD
Journal: Blood
Blood (2011) 118 (21): 2974.
https://doi.org/10.1182/blood.V118.21.2974.2974
Published: 2011
Journal Articles

Synergistic Effect of Anti-CD3 and Vorinostat in the Prevention of Acute Gvhd and Retention of GVL in a Radiation-Free Conditioning Regimen.

Wei He, PhD, MD, Mark Kirschbaum, MD, Nainong Li, PhD, MD, Tangsheng Yi, PhD, Hong-Jun Liu, Stephen Forman, MD, Defu Zeng, MD
Journal: Blood
Blood (2009) 114 (22): 3562.
https://doi.org/10.1182/blood.V114.22.3562.3562
Published: 2009
Journal Articles

The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D

Yan Kong, Wei Cao, Xueyan Xi, Chi Ma, Lianxian Cui, Wei He
Journal: Blood
Blood (2009) 114 (2): 310–317.
https://doi.org/10.1182/blood-2008-12-196287
Published: 2009
Journal Articles

Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI

Nainong Li, Ying Chen, Wei He, Tangsheng Yi, Dongchang Zhao, Chunyan Zhang, Chia-Lei Lin, Ivan Todorov, Fouad Kandeel, Stephen Forman, Defu Zeng
Journal: Blood
Blood (2009) 113 (4): 953–962.
https://doi.org/10.1182/blood-2008-06-165522
Published: 2009
Includes: Supplemental data
Journal Articles

Anti-CD3 Preconditioning Separates GVL from GVHD Via Modulating Host Dendritic and Donor T Cell Migration in TBI-Conditioned Recipients

Nainong Li, Ying Chen, Wei He, Tangsheng Yi, Dongchang Zhao, Chunyan Zhang, Chia-Lei Lin, Stephen Forman, Defu Zeng, MD
Journal: Blood
Blood (2008) 112 (11): 4611.
https://doi.org/10.1182/blood.V112.11.4611.4611
Published: 2008